Stay updated on Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page adds a recruitment update stating 'No longer looking for participants' and introduces new help/navigation sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. Additionally, the Intervention/Treatment header formatting was adjusted from 'Intervention / Treatment' to 'Intervention/Treatment'.
    Difference
    0.5%
    Check dated 2026-06-13T05:09:14.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page now displays revision: v3.5.5 at the bottom, replacing v3.5.4. This indicates a recent update to the site's revision label and rendering.
    Difference
    0.1%
    Check dated 2026-06-05T23:55:57.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.5.4, replacing the previous v3.5.3, indicating a minor update to the page version.
    Difference
    0.1%
    Check dated 2026-05-15T16:02:11.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    A footer release/version update was applied on the study page (updating the visible “Revision” number from v3.5.2 to v3.5.3). This reflects a site change rather than an alteration to the clinical trial details.
    Difference
    0.1%
    Check dated 2026-04-24T06:22:31.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:44:04.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    Added revision entry v3.5.0 and removed revision entry v3.4.3, affecting only the page's release metadata.
    Difference
    0.1%
    Check dated 2026-03-19T04:56:24.000Z thumbnail image

Stay in the know with updates to Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial page.